In a preliminary survey of TCGA, we noticed that among various glycosyltransferases involved in colon cancer, B4GALNT2 displayed a very good predictive potential in that patients retaining higher levels of B4GALNT2 mRNA displayed a much longer overall survival. Here, B4GALNT2 is linked to malignant colon neoplasm.